# OnCo record profoundbio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/profoundbio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "profoundbio" ;
  schema:name "ProfoundBio"@en ;
  schema:description "ProfoundBio developed antibodies that deliver a chemotherapy drug to ovarian cancer cells carrying a protein called folate receptor alpha. Genmab bought the company for 1.8 billion dollars in 2024."@en ;
  schema:url <https://onco.cc/companies/profoundbio/>, <https://www.genmab.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.genmab.com/>, <https://www.nasdaq.com/press-release/genmab-to-broaden-and-strengthen-oncology-portfolio-with-acquisition-of-profoundbio> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/folr1/> .